Lantibiotics: promising candidates for future applications in health care

Int J Med Microbiol. 2014 Jan;304(1):51-62. doi: 10.1016/j.ijmm.2013.09.003. Epub 2013 Sep 4.

Abstract

The immense potential of bacteria for production of antimicrobials represents an inexhaustible source of new antibiotics. An emerging class of natural products is constituted by ribosomally synthesized and posttranslationally modified peptides (RiPPs). "Lantibiotics" (lanthionine and/or methyl-lanthionine containing antibiotics) belong to the earliest members of this class. The characteristic thioether amino acids are introduced into the precursor peptides by enzyme-mediated posttranslational modifications. The encouraging antimicrobial activity of lantibiotics against multiresistant clinical pathogens, their stability against proteases, heat and oxidation make lantibiotics interesting candidates for novel antimicrobial applications in many areas of the healthcare sector and associated industries. In addition to applications as alternatives to classical antibiotics, lantibiotics can be used as probiotics, prophylactics or additives. Furthermore, the in vitro activity of the lantibiotic modification machinery opens the possibility to generate either improved synthetic lantibiotic peptides or to introduce thioether cross-links into existing therapeutics.

Keywords: Alternative therapeutics; Bacteriocins; Lanthipeptides; Lantibiotics; Multiresistant pathogens; Pharmaceutical applications.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / biosynthesis*
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteria / drug effects*
  • Bacteriocins / biosynthesis*
  • Bacteriocins / chemistry
  • Bacteriocins / therapeutic use*
  • Food Preservatives / chemistry
  • Food Preservatives / metabolism*
  • Humans

Substances

  • Anti-Bacterial Agents
  • Bacteriocins
  • Food Preservatives